Regeneron

ARCALYST

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Regeneron

Arcalyst HCPCS:

J2793

HCPCS Code Descriptor:

Injection, rilonacept, 1 mg

Category:

J Code

Arcalyst NDCs:

73604-0914-04

Primary Type:

Immunology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Arcalyst CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

73604-0914-04

About Arcalyst:

ARCALYST is an Immunology drug manufactured by Regeneron and administered via the Subcutaneous route of administration. The J Code: J2793 is aligned to the drug ARCALYST.

ACCESS PRICING AND MORE BY REGISTERING

J2793 Added Date:

January 1, 2010

J2793 Effective Date:

January 1, 2019

J2793 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Arcalyst billing and coding information.
Arcalyst patient assistance information can be found through Regeneron Pharmaceuticals at the URL: https://www.arcalyst.com/kiniksa-oneconnect-support#financial-assistance
ARCALYST prescribing information can be found at the link below:
Information regarding ARCALYST’s side effects can be found at MedlinePlus